Gunze's Medical Division mainly manufactures and sells bioabsorbable medical devices using highly biocompatible polymers and porcine-derived collagen. Gunze is the only company in Japan with such a comprehensive range of absorbable medical materials including suture thread. With 40% oftotal medical material sales achieved outside of Japan. Gunze is aiming to implement a more proactive global buisiness strategy. Our progressive R&D efforts are also moving toward tissue engineering, which is attracting growing attention. 1982 Started basic study with Kyoto University 1986 Entered into PGA suture market 1988 Medical Division established 1992 Launched "NEOVEIL" - PGA Felt- Sheet Type 1994 Launched "NEOVEIL" - PGA Felt- Tube Type 1995 Launched "NEOFIX" -Bioabsorbable Bone Fixation Device- in Japan 1996 Launched "PELNAC" - Artificial Dermis 2003 "NEOVEIL" CE certificate Launched "GRANDFIX" -Bioabsorbable Bone Fixation Device- in China 2005 Launched "SEAMDURA" -Bioabsorbable Artificial Dural Substitute- in Europe "SEAMDURA" CE certificate ISO 13485: 2003 certificate 2007 Medical Division SHENZHEN office (China) opened 2008 Launched "SEAMDURA " -Bioabsorbable Artificial Dural Substitute- in Japan 2010 Medical Materials Center was renamed to Medical Division as of April 1st. Sales Division (TOKYO) Nihonbashi 2-10-4, Chuo-ku, TOKYO 103-0027 Tel +81-3-3276-8718 Fax +81-3-3276-8696 China office (SHENZHEN) Shenzhen kerry centre 1112, 2008 Renminnan Rd., Luohu, SHENZHEN 518001 P.R.China Tel +86-755-8230-0236 Fax +86-755-8230-0237 Medical Division (KYOTO) 46 Natsumegaichi, Aono-cho, AYABE, Kyoto 623-8513 Established 1896 President & COO Hiroshi Hirata Capital 26,071 million yen (as of March 31, 2008) No. of employees Gunze Limited (non-consolidated) 2,279 Gunze Group (consolidated) 8,470 (as of March 31, 2008)